Jan Gursky

Jan Gursky

Auto-generated profile, based on publicly available information

Jan Gursky

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
ZSZdenek Skrott
Zdenek Skrott
DMDusana Majera
Dusana Majera
JGJan Gursky
Jan Gursky
TBTereza Buchtova
Tereza Buchtova
MHMarian Hajduch
Marian Hajduch
JBJiri Bartek
Jiri Bartek

9 April 2019 in Oncogene
Verified
Journal Article
Open access
PDF file
JŠJán Štetka
Ján Štetka
PVPavla Vyhlidalova
Pavla Vyhlidalova
LLLucie Lanikova
Lucie Lanikova
PKP. Koralkova
P. Koralkova
JGJ. Gursky
J. Gursky
VDVladimir Divoky
Vladimir Divoky
Inflammatory and oncogenic signaling converge in disease evolution of BCR–ABL-negative myeloproliferative neoplasms, clonal hematopoietic stem cell disorders characterized by gain-of-function mutation in JAK2 kinase (JAK2V617F), with highest prevalence in patients with polycythemia vera (PV). Despite the high risk, DNA-damaging inflammatory microenvironment, PV progenitors tend to preserve their genomic stability over decades until their progression to post-PV myelofibrosis/acute myeloid leukemia. Using induced pluripotent stem cells-derived CD34+ progenitor-enriched cultures from JAK2V617F+ PV patient and from JAK2 wild-type healthy control, CRISPR-modified HEL cells and patients’ bone marrow sections from different disease stages, we demonstrate that JAK2V617F induces an intrinsic IFNγ- and NF-κB-associated inflammatory program, while suppressing inflammation-evoked DNA damage both in vitro and in vivo. We show that cells with JAK2V617F tightly regulate levels of inflammatory cytokines-induced reactive oxygen species, do not fully activate the ATM/p53/p21waf1 checkpoint and p38/JNK MAPK stress pathway signaling when exposed to inflammatory cytokines, suppress DNA single-strand break repair genes’ expression yet overexpress the dual-specificity phosphatase (DUSP) 1. RNAi-mediated knock-down and pharmacological inhibition of DUSP1, involved in p38/JNK deactivation, in HEL cells reveals growth addiction to DUSP1, consistent with enhanced DNA damage response and apoptosis in DUSP1-inhibited parental JAK2V617F+ cells, but not in CRISPR-modified JAK2 wild-type cells. Our results indicate that the JAK2V617F+ PV progenitors utilize DUSP1 activity as a protection mechanism against DNA damage accumulation, promoting their proliferation and survival in the inflammatory microenvironment, identifying DUSP1 as a potential therapeutic target in PV.

1 January 2006 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
HHHana Hall
Hana Hall
JGJán Gurský
Ján Gurský
ANAndreas Nicodemou
Andreas Nicodemou
IRIvana Rybanská
Ivana Rybanská
EKErika Kimlíčková
Erika Kimlíčková
MPMiroslav Piršel
Miroslav Piršel